Product Information

ETRAVIRINE 200 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $8.7534 per EA under NDC 69452025517. Its NADAC has been published 42 times since Feb 4, 2026.

FDA first approved this application on Oct 2, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ETRAVIRINE 200 MG TABLET

etravirine
$8.7534per EA

Strength

200 mg/1

Manufacturer

Bionpharma Inc.

NDC

69452025517

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ETRAVIRINE

Approval Type

Generic (ANDA)

FDA Application

ANDA219152

FDA Approved

10/2/2025

TE Code

AB

On Market Since

1/1/2026

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 2C9 Inhibitors
Cytochrome P450 3A Inducers
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for ETRAVIRINE 200 MG TABLET has been published 42 times since Feb 4, 2026, and over the history we have for it it has declined 25.3%. The table below summarizes its recorded NADAC range and movement.

Current price$8.7534 per EA
All-time high$11.7118 (Feb 11, 2026)
All-time low$8.7534 (Nov 18, 2026)
52-week high$11.7118
52-week low$8.7534
Median price$11.2785
Average price$10.9409
Largest weekly change-7.8% (Sep 23, 2026)
Weeks tracked42
Tracking sinceFeb 4, 2026

Price History

1W

-5.2%

1M

-12.0%

3M

-18.9%

6M

-22.4%

1Y

N/A

3Y

N/A

5Y

N/A

All

-25.3%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ETRAVIRINE 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ETRAVIRINE 200 MG TABLET, manufactured by Bionpharma Inc., is $8.7534 per EA (NDC 69452025517), effective Nov 18, 2026.

How has the price of ETRAVIRINE 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for ETRAVIRINE 200 MG TABLET has declined 25.3%. It has been tracked across 42 weekly CMS publications since Feb 4, 2026.

What are the highest and lowest recorded NADAC prices for ETRAVIRINE 200 MG TABLET?

Since Feb 4, 2026, the NADAC for ETRAVIRINE 200 MG TABLET has ranged from a low of $8.7534 (Nov 18, 2026) to a high of $11.7118 (Feb 11, 2026), with a median of $11.2785 per EA.

Are there cheaper alternatives to ETRAVIRINE 200 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ETRAVIRINE 200 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ETRAVIRINE 200 MG TABLET?

ETRAVIRINE 200 MG TABLET (NDC 69452025517) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.